Evidence map›Paper›PMID 35205748›Full record

ArticleCancers2022

Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer.

Karel C Smit, Jeroen W G Derksen, Geerard L O Beets, Eric J Th Belt, Maaike Berbée, Peter Paul L O Coene, Hester van Cruijsen, Marjan A Davidis, Jan Willem T Dekker, Joyce M van Dodewaard-de Jong and 35 more

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors.

Karel C SmitJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.
Jeroen W G DerksenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.
Geerard L O BeetsDepartment of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0002-1671-9912
Eric J Th BeltDepartment of Surgery, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, 3318 AT Dordrecht, The Netherlands.
Maaike BerbéeDepartment of Radiotherapy, Maastro Clinic, 6202 NA Maastricht, The Netherlands.
Peter Paul L O CoeneDepartment of Surgery, Maasstad Hospital, Maasstadweg 21, 3079 DZ Rotterdam, The Netherlands.
Hester van CruijsenDepartment of Medical Oncology, Antonius Hospital, 8600 BA Sneek, The Netherlands.
Marjan A DavidisDepartment of Medical Oncology, Rivas, Banneweg 57, 4204 AA Gorinchem, The Netherlands.
Jan Willem T DekkerDepartment of Surgery, Reinier de Graaf Hospital, Reinier de Graafweg 5, 2600 GA Delft, The Netherlands.
Joyce M van Dodewaard-de JongDepartment of Medical Oncology, Meander Medical Center, Maatweg 3, 3813 TZ Amersfoort, The Netherlands.ORCID 0000-0003-2847-9060
Annebeth W HaringhuizenDepartment of Medical Oncology, Ziekenhuis Gelderse Vallei, 6710 HN Ede, The Netherlands.
Helgi H HelgasonDepartment of Medical Oncology, Haaglanden Medical Center, 2501 CK Den Haag, The Netherlands.
Mathijs P HendriksDepartment of Medical Oncology, Northwest Clinics, 1800 AM Alkmaar, The Netherlands.ORCID 0000-0001-6687-5393
Ronald HoekstraDepartment of Medical Oncology, Ziekenhuisgroep Twente, Zilvermeeuw 1, 7609 PP Hengelo, The Netherlands.
Ignace H J T de HinghDepartment of Surgery, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands.
Jan N M IJzermansDepartment of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 AD Rotterdam, The Netherlands.ORCID 0000-0003-3558-1039
Johan J B JanssenDepartment of Medical Oncology, Canisius Wilhelmina Hospital, 6500 GS Nijmegen, The Netherlands.
Joop L M KonstenDepartment of Surgery, Viecuri Hospital, Tegelseweg 210, 5912 BL Venlo, The Netherlands.
Maartje LosDepartment of Medical Oncology, St. Antonius Hospital, 3430 EM Nieuwegein, The Netherlands.
Leonie J M MekenkampDepartment of Medical Oncology, Medisch Spectrum Twente, 7500 KA Enschede, The Netherlands.
Peter NieboerDepartment of Medical Oncology, Wilhelmina Hospital, 9400 RA Assen, The Netherlands.
Koen C M J PeetersDepartment of Surgery, Leiden University Medical Center, University of Leiden, Postzone K6-39 Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Natascha A J B PetersDepartment of Medical Oncology, Sint Jans Hospital, Vogelsbleek 5, 6001 BE Weert, The Netherlands.
Hans J F M PruijtDepartment of Medical Oncology, Jeroen Bosch Hospital, 5200 ME Den Bosch, The Netherlands.
Patricia Quarles van Ufford-MannesseDepartment of Medical Oncology, Haga Hospital, Els Borst-Eilersplein 275, 2545 AA Den Haag, The Netherlands.
Ron C RietbroekDepartment of Medical Oncology, Rode Kruis Hospital, Vondellaan 13, 1942 LE Beverwijk, The Netherlands.
Anandi H W SchiphorstDepartment of Surgery, Diakonessenhuis Hospital, Bosboomstraat 1, 3582 KE Utrecht, The Netherlands.
Arjan Schouten van der VeldenDepartment of Surgery, St. Jansdal Hospital, Wethouder Jansenlaan 90, 3844 DG Harderwijk, The Netherlands.
Ruud W M SchrauwenDepartment of Gastroenterology and Hepatology, Bernhoven Hospital, Nistelrodeseweg 10, 5406 PT Uden, The Netherlands.
Mark P S SieDepartment of Medical Oncology, ZorgSaam Hospital, Wielingenlaan 2, 4535 PA Terneuzen, The Netherlands.
Dirkje W SommeijerDepartment of Medical Oncology, Academisch Medisch Centrum, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Dirk J A SonneveldDepartment of Surgery, Dijklander Hospital, Waterlandlaan 250, 1441 RN Purmerend, The Netherlands.
Hein B A C StockmannDepartment of Surgery, Spaarne Hospital, 2000 AK Haarlem, The Netherlands.
Marleen TentDepartment of Medical Oncology, Treant Hospital, 7800 RA Emmen, The Netherlands.
Frederiek TerheggenDepartment of Medical Oncology, Bravis Hospital, Boerhaavelaan 25, 4708 AE Roosendaal, The Netherlands.
Manuel L R Tjin-A-TonDepartment of Medical Oncology, Rivierenland Hospital, 4000 HA Tiel, The Netherlands.
Liselot Valkenburg-van IerselDepartment of Medical Oncology, Maastricht University Medical Center, 6202 NA Maastricht, The Netherlands.ORCID 0000-0003-2925-9908
Ankie M T van der VeldenDepartment of Medical Oncology, Tergooi Hospital, Van Riebeeckweg 212, 1213 XZ Hilversum, The Netherlands.
Wouter J VlesDepartment of Surgery, Ikazia Hospital, Montessoriweg 1, 3083 AN Rotterdam, The Netherlands.
Theo van VoorthuizenDepartment of Medical Oncology, Rijnstate Hospital, Postus 9555, 6800 TA Arnhem, The Netherlands.
Johannes A WegdamDepartment of Surgery, Elkerliek Hospital, Wesselmanlaan 25, 5707 HA Helmond, The Netherlands.ORCID 0000-0002-3287-0233
Johannes H W de WiltDepartment of Surgery, Radboud University Medical Center, University of Nijmegen, 6500 HB Nijmegen, The Netherlands.ORCID 0000-0001-6773-9668
Miriam KoopmanDepartment of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Anne M MayJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.
On Behalf Of The Plcrc Study Group

Funding

Regio Deal Foodvalley 162135
6 · The paper itself

Abstract

Regular physical activity (PA) is associated with improved overall survival (OS) in stage I-III colorectal cancer (CRC) patients. This association is less defined in patients with metastatic CRC (mCRC). We therefore conducted a study in mCRC patients participating in the Prospective Dutch Colorectal Cancer cohort. PA was assessed with the validated SQUASH questionnaire, filled-in within a maximum of 60 days after diagnosis of mCRC. PA was quantified by calculating Metabolic Equivalent Task (MET) hours per week. American College of Sports and Medicine (ACSM) PA guideline adherence, tertiles of moderate to vigorous PA (MVPA), and sport and leisure time MVPA (MVPA-SL) were assessed as well. Vital status was obtained from the municipal population registry. Cox proportional-hazards models were used to study the association between PA determinants and all-cause mortality adjusted for prognostic patient and treatment-related factors. In total, 293 mCRC patients (mean age 62.9 ± 10.6 years, 67% male) were included in the analysis. Compared to low levels, moderate and high levels of MET-hours were significantly associated with longer OS (fully adjusted hazard ratios: 0.491, (95% CI 0.299-0.807,

Indexed as

all-cause mortalitymetastatic colorectal cancerphysical activitysurvival

Identifiers

PMID35205748
PMCPMC8870120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.